Late Recognition of Andersen's Disease in Advanced Heart Failure
Cardiology and Angiology: An International Journal, Volume 11, Issue 4,
Page 347-351
DOI:
10.9734/ca/2022/v11i4289
Abstract
Glucogen storage diseases such as Andersen's disease are inherited disorders of carbohydrate metabolism. Cardiac involvement in Andersen's disease is extremely unusual and difficult to diagnose, especially in elderly individuals with atypical presentations. The following is a case of a 61-year-old man with a family history of muscle weakness who presented with congestive heart failure and was found to have Andersen disease cardiomyopathy. The diagnosis was made in view of the normal negative workup for cardiomyopathy, massive glucose tetrasaccharide excretion, and normal alpha-glucosidase activity. The patient rapidly deteriorated and passed away. This case highlights the need to consider storage diseases in adults with nonischemic dilated cardiomyopathy of uncertain etiology in the presence of liver or muscle involvement.
- Andersen
- disease
- GSD
- heart failure
- dilated cardiomyopathy
How to Cite
References
Magoulas PL, El-Hattab AW. Glycogen storage disease type IV. University of Washington, Seattle; 2019.
Kakkar A, Sharma MC, Nambirajan A, Sarkar C, Suri V, Gulati S. Glycogen storage disorder due to Glycogen Branching Enzyme (GBE) deficiency: A diagnostic dilemma. Ultrastructural Pathology. 2015;39(4):293-297.
Li SC, Chen CM, Goldstein JL, et al. Glycogen storage disease type IV: Novel mutations and molecular characterization of a heterogeneous disorder. J Inherit Metab Dis. 2010; 33(S3):83-90.
Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific Dilated Cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016; 134(23).
Sowell J, Wood T. Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses. Analytica Chimica Acta. 2011;686(1-2):102-106.
Schreuder AB, Rossi A, Grünert SC, Derks TG. Glycogen Storage Disease Type III. 21.
Heiner-Fokkema MR, van der Krogt J, de Boer F, et al. The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases. Genetics in Medicine. 2020; 22(11):1915-1916.
Andersen DH. Familial cirrhosis of the liver with storage of abnormal glycogen. Lab Invest. 1956;5:11-20.
Moses S, Parvari R. The variable presentations of glycogen storage disease type IV: A review of clinical, enzymatic and molecular studies. CMM. 2002;2(2):177-188.
Matern D, Starzl TE, Arnaout W, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr. 1999;158(2):S043-S048.
-
Abstract View: 215 times
PDF Download: 60 times
